CA2574831A1 - Biomarqueurs du cancer de la vessie - Google Patents
Biomarqueurs du cancer de la vessie Download PDFInfo
- Publication number
- CA2574831A1 CA2574831A1 CA002574831A CA2574831A CA2574831A1 CA 2574831 A1 CA2574831 A1 CA 2574831A1 CA 002574831 A CA002574831 A CA 002574831A CA 2574831 A CA2574831 A CA 2574831A CA 2574831 A1 CA2574831 A1 CA 2574831A1
- Authority
- CA
- Canada
- Prior art keywords
- marker
- biomarkers
- biomarker
- bladder cancer
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/575—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57557—Immunoassay; Biospecific binding assay; Materials therefor for cancer of other specific parts of the body, e.g. brain
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Oncology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59035004P | 2004-07-23 | 2004-07-23 | |
| US60/590,350 | 2004-07-23 | ||
| PCT/US2005/025632 WO2006020302A2 (fr) | 2004-07-23 | 2005-07-20 | Biomarqueurs du cancer de la vessie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2574831A1 true CA2574831A1 (fr) | 2006-02-23 |
Family
ID=35908003
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002574831A Abandoned CA2574831A1 (fr) | 2004-07-23 | 2005-07-20 | Biomarqueurs du cancer de la vessie |
Country Status (4)
| Country | Link |
|---|---|
| EP (1) | EP1784499A4 (fr) |
| AU (1) | AU2005274726A1 (fr) |
| CA (1) | CA2574831A1 (fr) |
| WO (1) | WO2006020302A2 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1775590A1 (fr) * | 2005-10-11 | 2007-04-18 | Laboratorios S.A.L.V.A.T., S.A. | Procédé non invasif pour la détection in vitro du carcinome transitionnel de la vessie |
| US8983580B2 (en) | 2008-01-18 | 2015-03-17 | The Board Of Trustees Of The University Of Illinois | Low-coherence interferometry and optical coherence tomography for image-guided surgical treatment of solid tumors |
| US8945511B2 (en) | 2009-06-25 | 2015-02-03 | Paul Weinberger | Sensitive methods for detecting the presence of cancer associated with the over-expression of galectin-3 using biomarkers derived from galectin-3 |
| EP2602621A1 (fr) * | 2011-12-08 | 2013-06-12 | Julius-Maximilians-Universität Würzburg | LASP-1, nouveau marqueur urinaire pour la détection du carcinome cellulaire transitionnel |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2320549A1 (fr) * | 2000-09-25 | 2002-03-25 | Eastern Virginia Medical College | Biomarqueurs de carcinome transitionnel de la vessie |
| US20060088830A1 (en) * | 2002-02-21 | 2006-04-27 | Eastern Virginia Medical School | Protein biomarkers that distinguish prostate cancer from non-malignant cells |
| WO2003091695A2 (fr) * | 2002-04-26 | 2003-11-06 | The Johns Hopkins University | Identification de marqueurs biologiques pour la detection du cancer de la prostate |
-
2005
- 2005-07-20 AU AU2005274726A patent/AU2005274726A1/en not_active Abandoned
- 2005-07-20 WO PCT/US2005/025632 patent/WO2006020302A2/fr not_active Ceased
- 2005-07-20 EP EP05804464A patent/EP1784499A4/fr not_active Withdrawn
- 2005-07-20 CA CA002574831A patent/CA2574831A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006020302A3 (fr) | 2006-06-08 |
| EP1784499A2 (fr) | 2007-05-16 |
| EP1784499A4 (fr) | 2007-08-22 |
| AU2005274726A1 (en) | 2006-02-23 |
| WO2006020302A2 (fr) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8173433B2 (en) | Platelet biomarkers for cancer | |
| CA2611173C (fr) | Biomarqueurs pour le cancer des ovaires | |
| US20080026410A1 (en) | Biomarkers for Bladder Cancer | |
| EP1838867B1 (fr) | Isoforme d'apolipoproteine a-ii utilisee en tant que biomarqueur pour le cancer de la prostate | |
| WO2004099432A2 (fr) | Identification de biomarqueurs permettant de detecter la presence d'un cancer du pancreas | |
| US20140038837A1 (en) | Biomarkers for the detection of early stage ovarian cancer | |
| US7951529B2 (en) | Biomarkers for breast cancer | |
| US20100173788A1 (en) | Biomarkers for breast cancer | |
| US20120172356A1 (en) | Serum biomarkers for chagas disease | |
| US20050181398A1 (en) | Specific detection of host response protein clusters | |
| US20090142332A1 (en) | Identification of Biomarkers by Serum Protein Profiling | |
| CA2574831A1 (fr) | Biomarqueurs du cancer de la vessie | |
| WO2006071843A2 (fr) | Biomarqueurs destines au cancer du sein | |
| AU2015210343B2 (en) | BIOMARKERS FOR OVARIAN CANCER: ß-2 MICROGLOBULIN | |
| US20150153348A1 (en) | BIOMARKERS FOR OVARIAN CANCER: Beta 2 MICROGLOBULIN |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |